Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case

• Egile Nagusiak: V. Shobha (Egilea), A.M. Desai (Egilea), T. Matthew (Egilea)
• Formatua: Liburua
• Argitaratua: PAGEPress Publications, 2019-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Anti-tumor necrosis factor drugs are used routinely according to treatment guidelines for several chronic rheumatologic problems. However, a rare and usually unpredictable adverse drug reaction namely peripheral nervous system demyelination is being increasingly recognized. Biosimilars are gaining m...